Familial Adenomatous Polyposis (FAP) is an inherited disorder causing numerous colon polyps, raising colorectal cancer risk.

Contribution of colibactin-producing Escherichia coli to colonic carcinogenesis
Go to source). The findings, published in eGastroenterology, highlight a potential role for gut microbes in accelerating cancer risk in people with a strong genetic predisposition.
TOP INSIGHT
What if a common #gutbacterium could be a silent partner in cancer? People with a specific type of #E_coli in their gut were more than three times as likely to have had #colorectalcancer. #GutHealth #Microbiome #CancerResearch
Linking a Gut Bacterium to Colorectal Cancer
High prevalence: The bacterium was found in a substantial proportion of patients, especially smokers.Surgery effect: No pks+ E. coli was detected in patients who had previously undergone colorectal surgery, suggesting that an intact microbiota is required for colonization.
Cancer link: Among non-surgical patients, those with prior colorectal cancer were over three times more likely to carry pks+ E. coli (risk ratio 3.25).
Tissue changes: Adenomas harboring the bacterium showed more DNA damage and signs of inflammation, including elevated IL-6, a pro-inflammatory cytokine.
The researchers propose that colibactin, a toxin produced by the bacterium, damages DNA and triggers inflammatory signals that may accelerate tumor progression in the already vulnerable colonic tissue of FAP patients.
The authors caution that the findings are preliminary and based on a relatively small patient group. Larger, multicenter studies are needed to confirm the results. If validated, the research could pave the way for new approaches, such as:
New Strategies for Colorectal Cancer: From Microbiome to Therapy
Microbiome-targeted prevention (probiotics, bacteriophages, or antibiotics).Risk screening through bacterial detection in stool or mucosal samples.
New therapies targeting colibactin-induced DNA damage and inflammation.
The study provides early but compelling evidence that colibactin-producing E. coli may play a role in colorectal cancer development in patients with familial adenomatous polyposis.
By shining light on the interplay between genes, microbes, and environment, the findings open new avenues for cancer prevention strategies in hereditary syndromes.
Reference:
- Contribution of colibactin-producing Escherichia coli to colonic carcinogenesis - (https://egastroenterology.bmj.com/content/3/2/e100177)
MEDINDIA




Email










